Auxilius provides clinical trial financial management software for Biopharma.
Auxilius has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in March 2024.
Auxilius's investors include Bain Capital Ventures, SignalFire, Renegade Partners, XYZ Venture Capital, Andy Palmer.
Auxilius is headquartered in Brooklyn, United States.
Auxilius provides clinical trial financial management software for Biopharma.
Auxilius is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Auxilius — Funding & Investors." VCBacked, March 15, 2024, https://www.vcbacked.co/company/auxilius. Accessed August 1, 2026.
VCBacked. (2024). Auxilius — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/auxilius
{{cite web |title=Auxilius — Funding & Investors |url=https://www.vcbacked.co/company/auxilius |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated